On June 18, 2015, Merz North America, Inc. (“Plaintiff”) filed a complaint against Cytophil, Inc., d/b/a Regenscientific, (“Defendant”) asserting infringement of U.S. Patent No. 6,537,574 (“the ‘574 Patent”). The ‘574 Patent is assigned to the Plaintiff and is drawn to soft tissue augmentation material. The Plaintiff is asserting that the Defendant is infringing the asserted patent by making, using, offering for sale, and/or selling Defendant’s product Renú® Voice, a product that is allegedly for implantation and soft tissue augmentation. The case remains pending and is captioned 5-15-cv-00262.
By: Jacqueline A. DiRamio